Drugs / pentoxyphylline
pentoxyphylline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT01144091 | Dec 2012 → Apr 2013 | diabetes mellitus | Meir Medical Center | Withdrawn | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT02687841 Comparator | Jan 2016 → Dec 2017 | acute kidney injury | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02051075 Comparator | Mar 2014 → May 2015 | infertility disorder | Rambam Health Care Campus | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pentoxyphylline | “Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation” NCT02051075 ↗ |
| Known as | pentoxiphylline | “Drug: pentoxiphylline” NCT01144091 ↗ |
| Known as | PTX | “pentoxyphylline (PTX)” NCT02687841 ↗ |
| Known as | PXN | “Treatment is usually based on inducing motility with pentoxyphylline (PXN) followed by ICSI.” NCT02051075 ↗ |
| Route | Oral | “pentoxyphylline 400mg QD PO x 10 days.” NCT02687841 ↗ |